Can an investigator requesting access to the resource for a genome wide SNP use samples and clinical data not currently in the NIDA Center for Genetic Studies?
A. Yes with the following conditions: It is expected that • A comprehensive and verified databases that contain clinical, diagnostic, pedigree structure, and genotypic information collected or produced exists for the clinical data • Unlimited amounts of High quality DNA are available, preferably through cell lines. • A mechanism or protocol and appropriate informed consent by which all databases and biological materials (DNA samples, cell lines) can be widely searched or distributed to qualified investigators in the scientific community • Clinical data and DNA will be available for distribution within 12 months after the genome wide association scan has been completed. • The clinical Data and DNA used in a publication are readily available for access by qualified investigators around the world. • The data collected must conform minimally to the data requirements for NIDA Genetic Consortium membership • Distribution of DNA and clinical data will be done at the expense of the investigato
Related Questions
- Can an investigator requesting access to the resource for a genome wide SNP use samples and clinical data not currently in the NIDA Center for Genetic Studies?
- The DNA consent form talks about Genome Wide Association Studies (GWAS); what is GWAS?
- Can an investigator retrieve samples stored in the repositories?
